Cargando…

Liquid biopsy: circulating tumor DNA monitors neoadjuvant chemotherapy response and prognosis in stage II/III gastric cancer

A good response to neoadjuvant chemotherapy (NACT) is strongly associated with a higher curative resection rate and favorable outcomes for patients with gastric cancer (GC). We examined the utility of serial circulating tumor DNA (ctDNA) testing for monitoring NACT response and prognosis in stage II...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Meng, Yang, Heli, Fu, Tao, Meng, Meizhu, Feng, Yi, Qu, Changda, Li, Zhongwu, Xing, Xiaofang, Li, Wenmei, Ye, Meiying, Li, Sisi, Bu, Zhaode, Jia, Shuqin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483607/ https://www.ncbi.nlm.nih.gov/pubmed/37356061 http://dx.doi.org/10.1002/1878-0261.13481

Ejemplares similares

Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial
por: Xue, Kan, et al.
Publicado: (2018)

ABCC2-24C > T polymorphism is associated with the response to platinum/5-Fu-based neoadjuvant chemotherapy and better clinical outcomes in advanced gastric cancer patients
por: Li, Ziyu, et al.
Publicado: (2016)

Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
por: Li, Ziyu, et al.
Publicado: (2020)

Organoids from patient biopsy samples can predict the response of BC patients to neoadjuvant chemotherapy
por: Shu, Dan, et al.
Publicado: (2022)

Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis
por: Xing, Xiaofang, et al.
Publicado: (2022)

Application of Data Science in Circulating Tumor DNA Detection: A Promising Avenue Towards Liquid Biopsy
por: Li, Ming, et al.
Publicado: (2021)

Liquid Biopsy of Hepatocellular Carcinoma: Circulating Tumor-Derived Biomarkers
por: Yin, Chang-Qing, et al.
Publicado: (2016)

Establishment of prognostic models for adenocarcinoma of oesophagogastric junction patients with neoadjuvant chemoradiotherapy: a real-world study
por: Du, Rongxu, et al.
Publicado: (2022)

Molecular characteristics of synchronous multiple gastric cancer
por: Wang, Anqiang, et al.
Publicado: (2020)

Circulating tumor cells and DNA as liquid biopsies
por: Heitzer, Ellen, et al.
Publicado: (2013)

A liquid biopsy signature of circulating exosome-derived mRNAs, miRNAs and lncRNAs predict therapeutic efficacy to neoadjuvant chemotherapy in patients with advanced gastric cancer
por: Guo, Ting, et al.
Publicado: (2022)

Prognostic impact of sarcopenia in patients with locally advanced adenocarcinoma of the esophagogastric junction treated with neoadjuvant chemoradiotherapy
por: Ming, Jiao, et al.
Publicado: (2023)

The Value of Perioperative Chemotherapy for Patients With Hepatoid Adenocarcinoma of the Stomach Undergoing Radical Gastrectomy
por: Zhou, Kai, et al.
Publicado: (2022)

Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer
por: Cheng, Feifei, et al.
Publicado: (2016)

Circulating platelets as liquid biopsy sources for cancer detection
por: Antunes‐Ferreira, Mafalda, et al.
Publicado: (2020)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

ARHGAP11A Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric Cancer
por: Fan, Biao, et al.
Publicado: (2021)

Integrated analysis toolkit for dissecting whole‐genome‐wide features of cell‐free DNA
por: Li, Jie, et al.
Publicado: (2023)

Advanced Nanotechnologies for Extracellular Vesicle‐Based Liquid Biopsy
por: Min, Li, et al.
Publicado: (2021)

Recent Advances in Liquid Biopsy Based on Circulating Tumor DNA
por: Sakuma, Yu, et al.
Publicado: (2019)

Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022)

Circulating microRNAs: Challenges with their use as liquid biopsy biomarkers
por: Takizawa, Satoko, et al.
Publicado: (2022)

Laser transfer for circulating tumor cell isolation in liquid biopsy
por: Molpeceres, Carlos, et al.
Publicado: (2023)

Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC
por: Li, Yilin, et al.
Publicado: (2023)

Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
por: Cheng, Xianliang, et al.
Publicado: (2017)

Up-Regulation of SALL4 Is Associated With Survival and Progression via Putative WNT Pathway in Gastric Cancer
por: Yang, Yang, et al.
Publicado: (2021)

Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor– Positive circulating tumor cells and HSP90
por: Huang, Maosen, et al.
Publicado: (2022)

The new horizon of liquid biopsy in sarcoma: the potential utility of circulating tumor nucleic acids
por: Wei, Junqiang, et al.
Publicado: (2020)

MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors
por: Meng, Ying, et al.
Publicado: (2021)

Capturing Genomic Evolution of Lung Cancers through Liquid Biopsy for Circulating Tumor DNA
por: Offin, Michael, et al.
Publicado: (2017)

Clinical applications of liquid biopsy as prognostic and predictive biomarkers in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Li, Jie, et al.
Publicado: (2018)

Depth of tumor invasion and tumor-occupied portions of stomach are predictive factors of intra-abdominal metastasis
por: Li, Ziyu, et al.
Publicado: (2017)

Nomograms for Predicting Disease-Free Survival Based on Core Needle Biopsy and Surgical Specimens in Female Breast Cancer Patients with Non-Pathological Complete Response to Neoadjuvant Chemotherapy
por: Lan, Ailin, et al.
Publicado: (2023)

New Concepts in Cancer Biomarkers: Circulating miRNAs in Liquid Biopsies
por: Larrea, Erika, et al.
Publicado: (2016)

Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
por: Grunvald, Miles W., et al.
Publicado: (2020)

Identification and validation of circulating exosomes‐based liquid biopsy for esophageal cancer
por: Zhao, An, et al.
Publicado: (2019)

Liquid Biopsy and Circulating Biomarkers for the Diagnosis of Precancerous and Cancerous Oral Lesions
por: Gattuso, Giuseppe, et al.
Publicado: (2022)

Circulating miRNA as a Biomarker in Oral Cancer Liquid Biopsy
por: Roi, Alexandra, et al.
Publicado: (2023)

Clinicopathological and Immunomicroenvironment Characteristics of Epstein–Barr Virus-Associated Gastric Cancer in a Chinese Population
por: Jia, Xiaoxia, et al.
Publicado: (2021)

Targeted axillary biopsy and sentinel lymph node biopsy for axillary restaging after neoadjuvant chemotherapy
por: Gurleyik, Gunay, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8uabdv624qgjo08ccpq3tobdpi